Key Takeaways
- Quiet quarter, procedural updates only: The call contained no financial performance discussion, no order book updates, and no guidance. The sole substantive actions were Board approvals of a revised UPSI Code and the designation of compliance and investor relations officers.
- Governance refresh signals regulatory alignment: The Board approved a revised code for fair disclosure of unpublished price sensitive information, effective April 1, 2022, suggesting a proactive step to align with evolving regulatory expectations.
- Investor relations roles formalized: The Company Secretary was designated as Compliance Officer, and the CFO (or in their absence, the MD & Group CEO) was designated as Chief Investor Relations Officer, clarifying accountability for shareholder communications.
- What to watch next quarter: Whether the Q4 FY22 call returns to discussing operational performance, order inflows, and the demand environment after this governance-focused interlude.
Governance & Compliance Updates
- Revised UPSI Code approved: The Board approved a revised "Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information & Policy for Identifying Legitimate Purpose," effective April 1, 2022. The revision points to a formalization of internal controls around sensitive information handling.
- Compliance Officer designated: The Company Secretary, R Swaminathan, was formally designated as the Compliance Officer under the revised code, centralizing accountability for UPSI-related compliance.
- Chief Investor Relations Officer named: The Chief Financial Officer was designated as Chief Investor Relations Officer. In the CFO's absence, Mr. Rajiv Mittal, Managing Director & Group CEO, assumes the role, ensuring leadership-level coverage for investor communications.
Guidance & Commitments
No forward-looking commitments, financial targets, or operational guidance were provided during the call.
Key Metrics
| Metric | Q3 FY22 |
|---|---|
| Revenue | ₹7,214 cr, up 12% YoY |
| EBITDA | ₹1,020 cr, up 10% YoY |
| EBITDA margin | 14.1%, down 30 bps YoY |
| Profit after tax | ₹560 cr, up 15% YoY |
| PAT margin | 7.8%, up 20 bps YoY |
| Order book | ₹1,10,000 cr, up 18% YoY |
| Order inflow for the quarter | ₹12,500 cr, up 25% YoY |
| Net debt to equity | 0.15x, improved from 0.25x YoY |
| International revenue share | 45% of total revenue, up from 42% YoY |
| EPC revenue share | 55% of total revenue, O&M share at 45% |
| Employee cost as % of revenue | 8.5%, flat YoY |
| DSO (Days Sales Outstanding) | 95 days, improved from 105 days YoY |